POS-287 TREATMENT BURDEN AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NON–DIALYSIS-DEPENDENT ANAEMIA OF CHRONIC KIDNEY DISEASE RECEIVING ERYTHROPOIESIS-STIMULATING AGENTS: A SYSTEMATIC LITERATURE REVIEW

• N. Rao,
• N. Webb,
• P. Bhatt,
• S. Grandy,
• J.J. Garcia Sanchez

Affiliations

N. Rao

AstraZeneca, Global Portfolio and Product Strategy, Cambridge, United Kingdom

N. Webb

Source Health Economics, Source Health Economics, London/Oxford, United Kingdom

P. Bhatt

AstraZeneca, Global Medical Affairs, Wilmington, United States

S. Grandy

AstraZeneca, Global Portfolio and Product Strategy, Cambridge, United Kingdom

J.J. Garcia Sanchez

AstraZeneca, Global Portfolio and Product Strategy, Cambridge, United Kingdom